Insider buying
~$1.5M3.49M sh @ $0.43
Traded Aug 29, 2025 · filed 5 days later
A Biodesix director paid $1.5M out of pocket for Biodesix shares. Shares held went up 17% with this purchase.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Aug 13, 2025 · Filed Aug 14, 2025
Biodesix's Chief Development Officer sold $184 of Biodesix shares. The filing references vesting of compensation awards.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$184
Shares × reported transaction price
6 days after results of Aug 7, 2025, 82 days before results of Nov 3, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +14.4% | +0.3% | +14.1% |
| 30 days | −4.1% | +2.7% | −6.8% |
| 90 days | −0.3% | +4.4% | −4.8% |
| 180 days | +30.6% | +7.5% | +23.0% |
| 365 days | +193.3% | +20.1% | +173.3% |
Past results only. Not a forecast.
Insider buying
Traded Aug 29, 2025 · filed 5 days later
A Biodesix director paid $1.5M out of pocket for Biodesix shares. Shares held went up 17% with this purchase.
Chris Vazquez (Chief Accounting Officer) sold ~$95 of Biodesix
Automatic saleKieran O'kane (Chief Commercial Officer) sold ~$198 of Biodesix
Automatic saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.